Who owns Regeneron Pharmaceuticals?

Key details on Regeneron Pharmaceuticals (Ticker: REGN)

Who owns Regeneron Pharmaceuticals?

Is REGN a good stock to own? Find out who bought Regeneron Pharmaceuticals, who sold Regeneron Pharmaceuticals (REGN) stock, and who holds a large position in Regeneron Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Capital World Investors^ 8.07M $3.36B Dec. 31, 2014
FMR 5.97M $2.15B Sept. 30, 2014
Wellington Management Company 5.88M $2.41B Dec. 31, 2014
Sands Capital Management 4.99M $2.05B Dec. 31, 2014
Artisan Partners Holdings 4.17M $236.54M June 30, 2011
Vanguard 4.01M $1.65B Dec. 31, 2014
T. Rowe Price Associates 3.94M $1.62B Dec. 31, 2014
STATE STREET CORPORATION 3.19M $1.31B Dec. 31, 2014
VIKING GLOBAL INVESTORS 2.96M $837.09M June 30, 2014
Icahn Capital 2.44M $109.84M March 31, 2011
Artisan Partners Limited Partnership 2.30M $945.63M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 1.99M $815.16M Dec. 31, 2014
BlackRock Fund Advisors 1.95M $798.19M Dec. 31, 2014
JPMORGAN CHASE & CO 1.76M $722.96M Dec. 31, 2014
Wells Fargo & Company 1.65M $466.47M June 30, 2014
GOLDMAN SACHS 1.46M $401.32M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 1.45M $435.11M March 31, 2014
Jefferies 1.34M $156.56M March 31, 2012
Citi 1.32M $73.23M Dec. 31, 2011
Gail Mannix 1.29M $71.59M Dec. 31, 2011
Inves 1.28M $526.55M Dec. 31, 2014

Who sold Regeneron Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ridgeback Capital Investments March 31, 2011 1.90M $85.39M